JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Butler, T. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Butler, T. C.
Journal of Pharmacology And Experimental Therapeutics, Vol. 100, Issue 2, 219-226, 1950
Copyright © 1950 by American Society for Pharmacology and Experimental Therapeutics


THE RATE OF PENETRATION OF BARBITURIC ACID DERIVATIVES INTO THE BRAIN

Thomas C. Butler 1

1 Department of Pharmacology and Experimental Therapeutics, The Johns Hopkins University, Baltimore, Maryland

Following intravenous injection of barbital and hexethal (Ortal) in mice, concentrations of the drugs in the brain have been determined by ultraviolet spectrophotometric methods.

The concentration of barbital in the brain rises gradually for a considerable time after the injection. The increasing concentration corresponds closely with the increasing intensity of neurological effects.

Hexethal, which shows immediate onset of anesthetic effects, attains its maximal concentration in the brain within a very short time after the injection.

It is concluded that the wide differences among the 5,5-disubstituted derivatives of barbituric acid with respect to the rate at which their anesthetic effects develop after intravenous injection are attributable to differences in the rates of penetration of the drugs from the blood into the brain.

Submitted on July 7, 1950




This article has been cited by other articles:


Home page
ScienceHome page
M Sharkawi and D Cianflone
Disulfiram enhances pharmacological activity of barbital and impairs its urinary elimination
Science, August 11, 1978; 201(4355): 543 - 544.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1950 by the American Society for Pharmacology and Experimental Therapeutics.